Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FATZL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,701
Award facts
- Contract value 100% obligated
- $5,700.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,700.82 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries no set-aside designation and will be performed at the company's facility in Conshohocken, Pennsylvania. This award represents a discrete purchase under DMS Pharmaceutical Group's broader relationship with the Defense Logistics Agency's Medical Supply Chain division.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion multi-year contract awarded in November 2025. The PPV-G GEN V program, part of the broader $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to supply pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders for diverse pharmaceutical categories, including specialty biologics and branded medications, positions the company as a critical supplier within the federal pharmaceutical supply chain serving the military medical system.
Quick answers
Who was awarded contract SPE2DB26FATZL?
SPE2DB26FATZL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZL worth?
The government has obligated $5,701 on SPE2DB26FATZL.
Is contract SPE2DB26FATZL an order under another contract?
Yes. SPE2DB26FATZL is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZL competed?
The extent of competition for SPE2DB26FATZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award